Luyue Chen

1.5k total citations
21 papers, 1.3k citations indexed

About

Luyue Chen is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Luyue Chen has authored 21 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Cancer Research and 2 papers in Genetics. Recurrent topics in Luyue Chen's work include Cancer-related molecular mechanisms research (11 papers), MicroRNA in disease regulation (10 papers) and RNA modifications and cancer (6 papers). Luyue Chen is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), MicroRNA in disease regulation (10 papers) and RNA modifications and cancer (6 papers). Luyue Chen collaborates with scholars based in China and United States. Luyue Chen's co-authors include Chunsheng Kang, Peiyu Pu, Lei Han, Zhendong Shi, Jianning Zhang, Kailiang Zhang, Junxia Zhang, Yu Ren, Jianwei Wei and Anling Zhang and has published in prestigious journals such as Cancer Research, Scientific Reports and Cancer Letters.

In The Last Decade

Luyue Chen

20 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luyue Chen China 14 1.1k 946 100 72 50 21 1.3k
Wenkang Luan China 21 1.2k 1.0× 1.1k 1.2× 47 0.5× 81 1.1× 96 1.9× 38 1.3k
Hai Yu China 16 565 0.5× 446 0.5× 67 0.7× 162 2.3× 35 0.7× 31 792
Yoji Hayashita Japan 4 1.5k 1.3× 1.4k 1.5× 22 0.2× 95 1.3× 35 0.7× 4 1.6k
Xuetao Li China 13 403 0.4× 311 0.3× 50 0.5× 59 0.8× 30 0.6× 20 543
Bernd B. Zeisig United Kingdom 18 1.3k 1.1× 222 0.2× 78 0.8× 156 2.2× 32 0.6× 25 1.4k
Shahryar E. Mir Netherlands 5 611 0.5× 263 0.3× 86 0.9× 204 2.8× 19 0.4× 5 737
Andrew E. Tee Australia 16 746 0.7× 373 0.4× 22 0.2× 133 1.8× 45 0.9× 18 909
Tianshi Que China 8 351 0.3× 248 0.3× 50 0.5× 64 0.9× 30 0.6× 15 480
Keshuo Ding China 18 646 0.6× 487 0.5× 16 0.2× 168 2.3× 29 0.6× 32 878

Countries citing papers authored by Luyue Chen

Since Specialization
Citations

This map shows the geographic impact of Luyue Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luyue Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luyue Chen more than expected).

Fields of papers citing papers by Luyue Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luyue Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luyue Chen. The network helps show where Luyue Chen may publish in the future.

Co-authorship network of co-authors of Luyue Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Luyue Chen. A scholar is included among the top collaborators of Luyue Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luyue Chen. Luyue Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tao, Chuming, et al.. (2021). Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma. Bioengineered. 12(1). 4016–4031. 19 indexed citations
3.
Chen, Luyue, Junhu Zhou, Qixue Wang, et al.. (2020). TGFβ signaling-induced miRNA participates in autophagic regulation by targeting PRAS40 in mesenchymal subtype of glioblastoma. Cancer Biology and Medicine. 17(3). 664–675. 5 indexed citations
4.
Chen, Luyue, et al.. (2020). Premature MicroRNA-Based Therapeutic: A “One-Two Punch” against Cancers. Cancers. 12(12). 3831–3831. 3 indexed citations
5.
Yang, Chao, Yanli Tan, Shouwei Li, et al.. (2019). Genomic landscapes by multiregion sequencing combined with circulation tumor DNA detection contribute to molecular diagnosis in glioblastomas. Aging. 11(23). 11224–11243. 5 indexed citations
6.
Chen, Luyue, et al.. (2018). Effect of HUK on the outcome of ruptured intracranial aneurysm. Brain and Behavior. 8(10). e01060–e01060. 1 indexed citations
7.
Sun, Jin, Xinhua Tian, Junqing Zhang, et al.. (2017). Regulation of human glioma cell apoptosis and invasion by miR-152-3p through targeting DNMT1 and regulating NF2. Journal of Experimental & Clinical Cancer Research. 36(1). 100–100. 73 indexed citations
8.
Wei, Jianwei, Jingqiu Cui, Xuan Zhou, et al.. (2016). F25P preproinsulin abrogates the secretion of pro-growth factors from EGFRvIII cells and suppresses tumor growth in an EGFRvIII/wt heterogenic model. Cancer Letters. 380(1). 1–9. 6 indexed citations
9.
Chen, Luyue, Lei Han, Jianwei Wei, et al.. (2015). SNORD76, a box C/D snoRNA, acts as a tumor suppressor in glioblastoma. Scientific Reports. 5(1). 8588–8588. 47 indexed citations
10.
Duan, Ran, Lei Han, Qixue Wang, et al.. (2015). HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF-β pathways. Oncotarget. 6(29). 27778–27793. 85 indexed citations
11.
Zhou, Xuan, Yu Ren, Jing Zhang, et al.. (2015). HOTAIR is a therapeutic target in glioblastoma. Oncotarget. 6(10). 8353–8365. 106 indexed citations
12.
Chen, Luyue & Chunsheng Kang. (2015). miRNA interventions serve as ‘magic bullets’ in the reversal of glioblastoma hallmarks. Oncotarget. 6(36). 38628–38642. 32 indexed citations
13.
Zhang, Junxia, Luyue Chen, Lei Han, et al.. (2014). EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma. Cancer Letters. 356(2). 929–936. 80 indexed citations
14.
Chen, Luyue, Kailiang Zhang, Zhendong Shi, et al.. (2014). A lentivirus-mediated miR-23b sponge diminishes the malignant phenotype of glioma cells in vitro and in vivo. Oncology Reports. 31(4). 1573–1580. 66 indexed citations
15.
Zhang, Kailiang, Yanwei Liu, Xiaoqun Dong, et al.. (2014). ICAT inhibits glioblastoma cell proliferation by suppressing Wnt/β-catenin activity. Cancer Letters. 357(1). 404–411. 37 indexed citations
16.
Zhang, Kailiang, Xiaotian Sun, Xuan Zhou, et al.. (2014). Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2 dependent manner. Oncotarget. 6(1). 537–546. 208 indexed citations
17.
Shi, Zhendong, Junxia Zhang, Qian Xiao-min, et al.. (2013). AC1MMYR2, an Inhibitor of Dicer-Mediated Biogenesis of Oncomir miR-21, Reverses Epithelial–Mesenchymal Transition and Suppresses Tumor Growth and Progression. Cancer Research. 73(17). 5519–5531. 157 indexed citations
18.
Zhang, Kailiang, Lei Han, Luyue Chen, et al.. (2013). Blockage of a miR-21/EGFR regulatory feedback loop augments anti-EGFR therapy in glioblastomas. Cancer Letters. 342(1). 139–149. 74 indexed citations
19.
Zhang, Junxia, Lei Han, Zhaoshi Bao, et al.. (2013). HOTAIR, a cell cycle–associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma. Neuro-Oncology. 15(12). 1595–1603. 198 indexed citations
20.
Shi, Zhendong, Qian Xiao-min, Junxia Zhang, et al.. (2012). Nuclear Translocation of β-catenin is Essential for Glioma Cell Survival. Journal of Neuroimmune Pharmacology. 7(4). 892–903. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026